paperKB
coga / coga-kb
Processing
Help
Sign in

bupropion associated_with smoking cessation

Subject
bupropion
Relation
associated_with
Object
smoking cessation
p-value
Evidence from: primary | all sources

Evidence (5 sources)

Predictors of relapse in a bupropion trial for smoking cessation in recently-abstinent alcoholics: preliminary results using an aggregate genetic risk score. (2012) PMID:23032639 cited
the bupropion literature ... are not available in the bupropion literature ... equivalent effects of each polymorphism on smoking cessation outcome.
confidence: 0.90
Predictors of relapse in a bupropion trial for smoking cessation in recently-abstinent alcoholics: preliminary results using an aggregate genetic risk score. (2012) PMID:23032639 cited
Participants were randomly assigned to bupropion ... to participate in a double-blind, placebo-controlled smoking cessation clinical trial.
confidence: 0.96
Predictors of relapse in a bupropion trial for smoking cessation in recently-abstinent alcoholics: preliminary results using an aggregate genetic risk score. (2012) PMID:23032639 cited
mixed findings in the smoking cessation literature... a more broadly-based AGRS that included additional variants implicated by bupropion’s pharmacology would have improved the ability of the AGRS to moderate treatment.
confidence: 0.80
Predictors of relapse in a bupropion trial for smoking cessation in recently-abstinent alcoholics: preliminary results using an aggregate genetic risk score. (2012) PMID:23032639 cited
The study models the complex genetics of smoking cessation and discusses pharmacogenetic predictors of bupropion response, implying bupropion’s relevance to smoking cessation.
confidence: 0.60
Pharmacogenetics of smoking cessation: role of nicotine target and metabolism genes. (2012) PMID:22290489 cited
FDA-approved approaches for smoking cessation include nicotine replacement therapy (NRT), bupropion, and varenicline.
confidence: 0.95